Docetaxel in non-small cell lung cancer: a review

Author： Davies Angela M Lara Jr Primo N Mack Philip C Gandara David R

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.4, 2003-04, pp. : 553-565

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docetaxel: A Review of its Use in Non-Small Cell Lung Cancer

By Comer A.M. Goa K.L.

Drugs & Aging, Vol. 17, Iss. 1, 2000-07 ,pp. : 53-80

Adis International

Access to resources Recommend Favorite

Docetaxel in Non-Small Cell Lung Cancer: Impact on Quality of Life and Pharmacoeconomics

By Horn Leora Visbal Antonio Leighl Natasha B.

Drugs & Aging, Vol. 24, Iss. 5, 2007-01 ,pp. : 411-428

Adis International

Access to resources Recommend Favorite

Combination Chemotherapy with Docetaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer

By Schuette W.

Clinical Drug Investigation, Vol. 21, Iss. 3, 2001-03 ,pp. : 161-168

Adis International

Access to resources Recommend Favorite

Erlotinib in non-small cell lung cancer: a review

By Blackhall Fiona H Rehman Shazza Thatcher Nicholas

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 6, 2005-06 ,pp. : 995-1002

Informa Healthcare

Access to resources Recommend Favorite

Non–Small Cell Lung Cancer

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 3, 2008-03 ,pp. : 228-228

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite